Monte Rosa Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026

GLUE

Published on 05/07/2026 at 11:51 am EDT

Monte Rosa Therapeutics, Inc. reported earnings results for the first quarter ended March 31, 2026. For the first quarter, the company reported net loss was USD 44.5 million compared to net income of USD 46.89 million a year ago.